Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30914 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Ashley Carlo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology/Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA. Hauptthemen laut MEDLINE: Dickeya chrysanthemi, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Erwinia, Leukemia, Myeloid, Acute. Die Arbeit nennt 10 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology/Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Department of Pediatrics, Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Department of Pediatric Endocrinology, Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Department of Pharmacy, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Zitieren
APA
Carlo, A., Watson, A., Klein, G., Ghanny, S., Tell, S., Horowitz, T., Siver, M., Appel, B., & Chen, J. (2024). Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30914
Vancouver
Carlo A, Watson A, Klein G, Ghanny S, Tell S, Horowitz T, et al. Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30914
BibTeX
@article{Carlo2024,
author = {Carlo, Ashley and Watson, Ally and Klein, Genna and Ghanny, Steven and Tell, Shoshana and Horowitz, Tamar and Siver, Molly and Appel, Burton and Chen, Jing},
title = {Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30914}
}
EUVIMED